WASHINGTON, Oct. 28, 2020 /PRNewswire/ -- As part of its commitment to community engagement and organizational capacity building, the National Organization...

Changing the healthcare habits of older adults is a tall order, but GlaxoSmithKline set out to do just that when it launched its first general vaccination aware...

Sanofi and GlaxoSmithKline aren’t the front-runners in the race for a COVID-19 vaccine, but execs for the companies have said they expect to play an important role i...

AstraZeneca and Daiichi Sankyo are rapidly gaining traction for their Enhertu in HER2-positive breast cancer. Next up? An early chance at expanding the blockbus...

Consumer complaints are a serious issues for drugmakers, particularly for those making sterile injectables. When a complaint does come in, companies are supposed to ...

Sanofi and Regeneron's immunology superstar Dupixent is well on its way to world domination with a flood of new indications in the pipeline. To support one of t...

Fresh off new data showing their Opdivo-plus-Cabometyx combo can help kidney cancer patients live longer, Bristol Myers Squibb and Exelixis are getting VIP treatment...

AbbVie's Allergan business has once again drafted Super Bowl MVP—and Dancing with the Stars celebrity—Von Miller to feature in their latest glaucoma awareness campai...

The COVID-19 pandemic has put a damper on the FDA's on-site inspections in 2020, but that doesn't mean the agency isn't making the rounds and putting drugmakers on n...

In the age of artificial intelligence, no trial data should be going to waste. Findacure’s Rick Thompson looks at how these technologies could bring us closer to tre...